Methotrexate for the Treatment of Crohn's Disease
- 2 February 1995
- journal article
- clinical trial
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 332 (5), 292-297
- https://doi.org/10.1056/nejm199502023320503
Abstract
Although corticosteroids are highly effective in improving symptoms of Crohn's disease, they may have substantial toxicity. In some patients, attempts to discontinue corticosteroids are unsuccessful.Keywords
This publication has 28 references indexed in Scilit:
- Oral Budesonide for Active Crohn's DiseaseThe New England Journal of Medicine, 1994
- Low-Dose Cyclosporine for the Treatment of Crohn's DiseaseThe New England Journal of Medicine, 1994
- Oral cyclosporin for chronic active Crohnʼs diseaseEuropean Journal of Gastroenterology & Hepatology, 1994
- Methotrexate for Rheumatoid ArthritisArthritis & Rheumatism, 1994
- A Placebo-Controlled, Double-Blind, Randomized Trial of Cyclosporine Therapy in Active Chronic Crohn's DiseaseThe New England Journal of Medicine, 1989
- Predictors of acute relapse of Crohn's diseaseDigestive Diseases and Sciences, 1987
- Efficacy of Low-Dose Methotrexate in Rheumatoid ArthritisThe New England Journal of Medicine, 1985
- Methotrexate in Rheumatoid ArthritisThe New England Journal of Medicine, 1985
- Prognosis in Crohn's disease--based on results from a regional patient group from the county of Copenhagen.Gut, 1985
- Randomized, Double‐Blind, Placebo Controlled Trial of Low‐Dose Pulse Methotrexate in Psoriatic ArthritisArthritis & Rheumatism, 1984